Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma

  • Authors:
    • Kai‑Fu Kang
    • Xiao‑Wei Wang
    • Xiao‑Wu Chen
    • Zi‑Jing Kang
    • Xin Zhang
    • Rhonda R. Wilbur
    • Feng Cheng
    • Shu‑Feng Zhou
  • View Affiliations

  • Published online on: April 16, 2013     https://doi.org/10.3892/ol.2013.1307
  • Pages: 1813-1818
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

There are no sensitive and specific biomarkers that aid in the clinical diagnosis and prognosis of hepatocellular carcinoma (HCC). The aim of the present study was to determine the mRNA and protein expression levels of beclin 1 (BECN1) and nuclear factor‑κB (NF‑κB)p65 in patients with HCC, to evaluate their value as potential diagnostic and prognostic biomarkers. Immunohistochemistry and in situ hybridization were used to detect the expression of hepatic BECN1 and NF‑kBp65 in patients with HCC, hepatitis B virus (HBV) or cirrhosis, as compared with the expression levels in healthy subjects. The expression level of the BECN1 protein in the HCC tissue was significantly high compared with that in the cirrhotic, hepatitis and normal tissues. The expression of the BECN1 protein in the hepatitis tissue was significantly high compared with that of the cirrhotic and normal tissues. The expression of the BECN1 mRNA in the cancer tissue was significantly high compared with that of the cirrhotic and normal tissues, and the expression of the BECN1 mRNA in the hepatitis tissue was significantly higher than that of the cirrhotic and normal tissues. The expression of the NF‑κBp65 protein in the cancer tissue was significantly high compared with that of the cirrhotic, hepatitis and normal tissues. The expression of the NF‑κBp65 mRNA in the cancer tissue was significantly high compared with that of the cirrhotic, hepatitis and normal tissues. BECN1 expression was positively correlated with NF‑κBp65 expression in HCC. The abnormal expression of BECN1 and NF‑κBp65 was closely associated with the development of HCC. Finally, a search in GeneGo pathway database observed a link between BECN1 and NF-κBp65 through multiple proteins. These results indicate that BECN1 and NF‑κBp65 are upregulated in HCC, and that they may serve as useful biomarkers for HCC.
View Figures
View References

Related Articles

Journal Cover

June 2013
Volume 5 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang KF, Wang XW, Chen XW, Kang ZJ, Zhang X, Wilbur RR, Cheng F and Zhou SF: Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma. Oncol Lett 5: 1813-1818, 2013
APA
Kang, K., Wang, X., Chen, X., Kang, Z., Zhang, X., Wilbur, R.R. ... Zhou, S. (2013). Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma. Oncology Letters, 5, 1813-1818. https://doi.org/10.3892/ol.2013.1307
MLA
Kang, K., Wang, X., Chen, X., Kang, Z., Zhang, X., Wilbur, R. R., Cheng, F., Zhou, S."Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma". Oncology Letters 5.6 (2013): 1813-1818.
Chicago
Kang, K., Wang, X., Chen, X., Kang, Z., Zhang, X., Wilbur, R. R., Cheng, F., Zhou, S."Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma". Oncology Letters 5, no. 6 (2013): 1813-1818. https://doi.org/10.3892/ol.2013.1307